Does BROMAZEPAM Cause Basal cell carcinoma? 11 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Basal cell carcinoma have been filed in association with BROMAZEPAM. This represents 0.2% of all adverse event reports for BROMAZEPAM.
11
Reports of Basal cell carcinoma with BROMAZEPAM
0.2%
of all BROMAZEPAM reports
0
Deaths
11
Hospitalizations
How Dangerous Is Basal cell carcinoma From BROMAZEPAM?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BROMAZEPAM Alternatives Have Lower Basal cell carcinoma Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE